These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7555197)

  • 1. New antithrombotics.
    Weitz JI; Califf RM; Ginsberg JS; Hirsh J; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):471S-485S. PubMed ID: 7555197
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis in congenital heart disease.
    Khairy P
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1579-82. PubMed ID: 24215186
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW
    Chest; 2001 Jan; 119(1 Suppl):228S-252S. PubMed ID: 11157652
    [No Abstract]   [Full Text] [Related]  

  • 4. New thrombin inhibiting strategies for coronary artery disease.
    Shah PK; Parikh A
    Indian Heart J; 1995; 47(4):381-6. PubMed ID: 8557285
    [No Abstract]   [Full Text] [Related]  

  • 5. Are new antithrombotics the modern fountain of youth? Achievements and limitations.
    Moser M; Bode C
    Hamostaseologie; 2012; 32(3):176. PubMed ID: 22859264
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic agents in coronary artery disease.
    Cairns JA; Lewis HD; Meade TW; Sutton GC; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):380S-400S. PubMed ID: 7555191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Your patient needs antithrombotics: leg venous thrombosis : how to proceed?].
    MMW Fortschr Med; 2014 Mar; 156(4):28. PubMed ID: 24908764
    [No Abstract]   [Full Text] [Related]  

  • 8. Stabilizing unstable plaque in acute coronary syndromes: implications for cardiac surgical patients.
    Weber MM; McErlean ES
    Crit Care Nurse; 2000 Aug; 20(4):78-91. PubMed ID: 11876339
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and management of thrombotic complications during coronary interventions. Proceedings of a conference. Sophia Antipolis, France, 16-18 February 1995.
    Eur Heart J; 1995 Nov; 16 Suppl L():1-107. PubMed ID: 8983927
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy for cerebrovascular disorders. An update.
    Sherman DG; Dyken ML; Gent M; Harrison JG; Hart RG; Mohr JP
    Chest; 1995 Oct; 108(4 Suppl):444S-456S. PubMed ID: 7555195
    [No Abstract]   [Full Text] [Related]  

  • 12. New antithrombotics for the treatment of acute and chronic arterial ischemia.
    Hirsh J
    Vasc Med; 1996; 1(1):72-8. PubMed ID: 9546919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
    Popma JJ; Ohman EM; Weitz J; Lincoff AM; Harrington RA; Berger P
    Chest; 2001 Jan; 119(1 Suppl):321S-336S. PubMed ID: 11157657
    [No Abstract]   [Full Text] [Related]  

  • 15. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update.
    Vandermeulen E; Singelyn F; Vercauteren M; Brichant JF; Ickx BE; Gautier P; ;
    Acta Anaesthesiol Belg; 2005; 56(2):139-46. PubMed ID: 16013658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Haemostaseology].
    Schrör K
    Internist (Berl); 2005 Aug; 46(8):873-8, 880-1. PubMed ID: 15988604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis.
    Al-Quthami AH; Jumean M; Kociol R; Pham DT; Kiernan M; DeNofrio D; Kapur NK
    Circ Heart Fail; 2012 Jul; 5(4):e68-70. PubMed ID: 22811551
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates.
    Ledizet M; Harrison LM; Koskia RA; Cappello M
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):1-10. PubMed ID: 15638739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary thrombosis in diabetes: Are we doing enough?
    Ajjan RA
    Diab Vasc Dis Res; 2016 Nov; 13(6):445-448. PubMed ID: 27555606
    [No Abstract]   [Full Text] [Related]  

  • 20. A guide to drug use during percutaneous coronary intervention.
    Choo JK; Young JJ; Kereiakes DJ
    Drugs; 2002; 62(18):2589-601. PubMed ID: 12465999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.